Project Grant K99CA312752
Award Date 6/1/26
Completion Date 5/31/28
Dollars Obligated $117K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Chapel Hill, NC 27599, USA
Similar Awards
- Federal Grant Award Summary The National Cancer Institute (NCI) awarded the University of Virginia a $192,887 Project Grant under the Cancer Research Manpower program (CFDA 93.398) beginning May 8, 2026, with an ultimate completion date of April 30, 2029. This award supports biomedical research and training focused on sphingolipid-guided stratification and therapeutic opportunities in acute myeloid leukemia (AML). The project delivers research services aimed at improving AML risk...
- Federal Project Grant Award Summary The National Cancer Institute awarded a Project Grant totaling $194,914 under the Cancer Research Manpower program (CFDA 93.398) on September 15, 2025, to support cancer research training and investigator development. This award funds research led by Dr. Xu examining how structural variants (SVs) contribute to oncogene activation in cancer through genome engineering and single-cell sequencing approaches. The project runs through August 31, 2028, and will be...
- Federal Grant Award Summary The National Cancer Institute (NCI) awarded a $323,860 Project Grant to Sloan-Kettering Institute for Cancer Research under the Cancer Research Manpower program (CFDA 93.398) on August 18, 2025, with completion targeted for April 30, 2028. This award supports research investigating the role of mutagenic DNA repair pathways in cancer cell persistence and acquired drug resistance. The project focuses on understanding how cancer cells under stress from anti-cancer...
- Federal Project Grant Award Summary The National Cancer Institute (NCI), under the Cancer Research Manpower program (CFDA 93.398), awarded $129,058 to the University of Southern California beginning September 1, 2025, through August 31, 2027. This K99/R00 Pathway to Independence Award supports Dr. Anqi Wang's transition to an independent investigator in cancer and molecular epidemiology. The award funds comprehensive research training and mentored career development focused on investigating...
- Federal Project Grant Award Summary The National Cancer Institute (NCI) awarded the University of North Carolina at Chapel Hill a $117,018 Project Grant under the Cancer Research Manpower program (CFDA 93.398) effective August 1, 2025, through July 31, 2027. This mentored K99 award supports Dr. Overchuk's research training and investigation into photodynamic priming (PDP) as a complementary strategy to enhance chemotherapy efficacy in high-grade serous ovarian carcinoma (HGSOC) with peritoneal...
- Federal Grant Award Summary The National Cancer Institute (NCI) awarded Fred Hutchinson Cancer Center a $140,854 Project Grant under the Cancer Research Manpower program (CFDA 93.398) effective July 1, 2025, through December 31, 2026. This K99/R00 Pathway to Independence Award supports research training and career development for Dr. Karl Cristie Figuracion, PhD, ARNP, a postdoctoral research fellow transitioning to an independent scientist. The award funds a structured training and mentorship...
- Federal Grant Award Summary New York University School of Medicine received a $149,190 Project Grant from the National Cancer Institute (NCI) under the Cancer Research Manpower program (CFDA 93.398), effective December 1, 2025, with completion by May 6, 2027. This award supports biomedical research training and investigator development in cancer research aligned with the National Cancer Program's strategic priorities. The funded research project focuses on elucidating the mechanisms of DNA...
- Federal Grant Award Summary The National Cancer Institute awarded the University of Virginia $115,420 under the Cancer Research Manpower program (CFDA 93.398) for a K99/R00 Pathway to Independence Award beginning May 1, 2026 and concluding April 30, 2028. Dr. Kelsey Day will utilize this funding to develop a multilevel, faith-based intervention designed to promote physical activity in rural communities as a cancer prevention strategy. The award supports Dr. Day's transition to independent...
- Federal Project Grant Award Summary The National Cancer Institute (NCI) awarded $169,884 on September 1, 2025, under the Cancer Research Manpower program (CFDA 93.398) to support a K22 Transition Career Development Award at Beth Israel Deaconess Medical Center. The award funds Dr. Jingyi Wu's research program investigating the role of genetic and epigenetic variation in the progression of isocitrate dehydrogenase (IDH) mutant gliomas through August 31, 2028. The project delivers advanced...
- Federal Grant Award Summary The University of Pittsburgh received a $141,566 Project Grant award from the National Cancer Institute (NCI) under the Cancer Research Manpower program (CFDA 93.398), effective March 24, 2026, with completion targeted for February 28, 2028. This K99/R00 Pathway to Independence Award supports research career development focused on understanding small GTPase (SMG) regulation and function in cancer environments. The grant funds research activities aimed at developing...